MRNA 目前太贵；若回调至 210 可能是买入机会，但跌破 210 则有更深下跌风险，而一旦跌破关键的高位低点，可能回落至 50。上升趋势仍完好，守住上升的锚点和向上倾斜的 20 日均线；高波动加大了回调风险，但目前尚未出现回调迹象。
逐段跳播
我们的一位忠实观众，聊天室里的Arun Warrior，想多了解一些Moderna的情况。我们喜欢Moderna的故事，对吧？mRNA。我的意思是，嗯，与Merck合作在癌症方面取得了多么巨大的进展，而现在有点……
我不知道。我们只能看看这对未来意味着什么。但这只股票确实对那个峰值做出了反应。
One of our loyal viewers, Arun Warrior in the chat , would like to know a bit more about Moderna . We love the story of Moderna, don't we? mRNA. I mean, um, what a tremendous rise with Cancer, together with Merck, and now a bit...
I do n't know. We will just have to see what that means for the future. But the stock really responded to the peak.
这些是你曾经想投资的标的吗？嗯，我们现在是不是太高了？我知道说实话这些都是反问，但看起来市场变得非常兴奋，持有长仓的投资者在想：我们现在该怎么处理这个仓位？我们应该等它再次下跌吗？
还是应该加仓？嗯，是不是……我的意思是，在我看来它的估值太高了。你大概可以加一大堆数据来证明这一点，因为他们自上次发现以来还没有做过财报发布。但你怎么看Moderna这样的股票？
Are these names you ever wanted to invest in? Um, are we way too high here? I know these are all rhetorical questions, to be honest, but it seems the market is getting very excited and investors with a long position are wondering: what should we do with this position now?
Shall we wait until it drops again? Or should we buy more? Um, is it... I mean, it seems way too highly rated to me. You could probably add a whole lot of figures to prove that, because we still haven't had an earnings presentation since their last discovery. But what do you think of a stock like Moderna?
对我来说，它现在有点太贵了。大概是跌到190，我想你上周已经问过这个好几次了。但这是我们节目里总会提到的话题。所以你现在怎么看Moderna？
For me, it is a bit too expensive right now. Probably the drop to 190, and I think you already asked this a few times last week. But it is a topic that always comes up in our show. So what do you think of Moderna now?
我会说：跳空高开，一点盘整，再一个跳空。我们现在在盘整，甚至看起来可能还会跳空走高。我会说：在210的回调处买入。我们是不是从那个点位开始接近定投策略了？然后再回到Moderna？
I would say: a gap up, a bit of consolidation, another gap. We are consolidating a bit now, and it even looks like it might gape higher. I would say: buy on a dip of 210. Are we perhaps close to a DCA strategy from that point? And then get back into Moderna?
嗯，看看这张图，Sean，你可以看到他们下一次财报发布是在11月6日。所以暂时不用担心那个。但你知道，我们上周已经谈过这个了。而且我认为我们曾把这个确定为衡量风险的最重要的更高低点，意思是如果那个低点被跌破，价格可能会回落到50。
Um, take a look at this chart, Sean, you can see that their next earnings presentation is on November 6th. So we don't have to worry about that for the time being. But you know, we already talked about this last week .
And I think we had identified this as the most important higher bottom to gauge risk, in the sense that if that bottom is broken, the price might fall back to 50.
但价格继续上涨，并且很好地守住了那条上升的锚点线。以收盘价计算，价格持续收在其上方。它下方还有一条向上倾斜的红色20日移动平均线。所以我认为你可以在当前这个低点下方设置部分止损。
上周五我们经历了一次相当强的回调，那大概是周四或周五。无论如何，我们从中恢复得很好。所以，在我看来，跌破210可能是个问题，可能导致更深的下跌。
But the price has continued to rise and is holding on nicely to that rising anchor line. On a closing basis, the price consistently closes above. There is also a red 20- day moving average line that slopes upwards underneath it.
So I think you could place a partial stop-loss below this low here . We had a fairly strong correction last Friday, and that was perhaps Thursday or Friday. In any case , we have recovered very well from it .
So, in my opinion, a breakthrough below 210 could be a problem that could lead to a somewhat deeper decline .
这里的市场相当过热。我们刚刚看到从130到2240的这波走势。这是在短时间内巨大的百分比波动。到目前为止，我们看到的是随时间推移的回调，这很好。但现在我们开始看到更大的波动性。
这让我觉得这种高波动性带有风险，我们可能正走向更深的回调。目前还没有证据表明这一点。所以我会说：以210这个水平来衡量。
The market is quite overheated here. We have just seen this movement from 130 to 2240. That is a huge percentage movement in a short period. So far, we have seen a correction over time , which is great.
But now we are starting to see greater volatility here. That makes me think that this high volatility carries the risk that we might be heading for a deeper pullback. There is no evidence for that yet.
That is why I would say: measure it against the level of 210.
这个频道对 $MRNA 的历次判断
Brian Shannon 在这只股票上共 6 条判断，这里只列相邻的几条。